Loading…
Loading…
The moves that matter — curated from across forex, stocks and crypto, and readable in full right here.
Updated 30 Jun, 11:00 pm
Strong Analyst Sentiment : Merck & Co., Inc. (NYSE: MRK) holds an average brokerage recommendation of 1.73 , indicating a "Strong Buy" to "Buy" rating for the pharmaceutical stock. Increased Price Target : Scotiabank raised its price target for Merck to $155 , signaling increased
The consensus price target for Nike has significantly decreased over the past year, reflecting adjusted expectations due to recent performance and market conditions. Analysts project a notable decline in Nike's Q4 revenue, operating income, and EPS, indicating potential headwinds
Wedbush analyst Laura Chico has increased her price target for Viridian Therapeutics to $43 , signaling strong confidence in the biopharmaceutical company's future. The U.S. Food and Drug Administration (FDA) has approved Viridian Therapeutics' new drug, Lumvoa, for Thyroid Eye D
Scotiabank raised its price target for Merck to $155.00 from $136.00 , maintaining an "Outperform" rating. The wider analyst community, including Zacks Investment Research, gives Merck an average brokerage recommendation of 1.73 , indicating a strong "Buy" consensus. Merck's stoc
Analyst Jeff Van Rhee of Craig-Hallum has raised the price target for Rocket Lab (NASDAQ: RKLB) to $120.00 , signaling strong confidence in the company's future. Rocket Lab is set to acquire Iridium Communications (NASDAQ: IRDM) in an approximately $8.00 billion cash-and-stock de
Earnings Growth Expected: Analysts project an increase in earnings per share and revenue for Progress Software's upcoming quarterly report. Positive Stock Momentum: The company's shares have shown recent strength, with a notable 11.2% surge in a recent trading session. Financial
Deutsche Bank's Positive Outlook: The bank reiterated a "Buy" rating for UBS, raising its price target to CHF 45 . Strategic U.S. Wealth Management Expansion: UBS is growing its presence in the U.S. by adding new financial advisor teams managing over $2.00 billion in assets. Evol
Mobile-health Network Solutions (NASDAQ: MNDR) executed a one-for-six reverse stock split on June 29, 2026, to increase its share price and maintain its Nasdaq listing. The reverse split reduced outstanding Class A Ordinary Shares from approximately 5.33 million to about 888,592
Jefferies increased its price target for Life Time Group to $51.00 , suggesting a 24.9% potential upside. Life Time Group shares have gained 31.2% year-to-date, significantly outperforming the broader Zacks Consumer Discretionary sector. The company consistently beats earnings es
Iridium Communications (NASDAQ:IRDM) received a "Perform" rating downgrade from Oppenheimer, shifting from "Outperform," following its acquisition by Rocket Lab. Rocket Lab is acquiring Iridium Communications in a significant cash-and-stock deal valued at approximately $8 billion
Honeywell Technologies is undergoing a significant restructuring, spinning off business segments into independent entities like Honeywell Aerospace and Solstice Advanced Materials to enhance focus and flexibility. A 1-for-2 reverse stock split for Honeywell Technologies is effect
Analyst David Hoang of Deutsche Bank has raised the price target for Acadia Pharmaceuticals (NASDAQ: ACAD) to $37.00 , citing positive developments. The European Medicines Agency (CHMP) has recommended the approval of Acadia Pharmaceuticals' drug, DAYBU, for Rett syndrome, markin
Cowen & Co. maintains a "Buy" rating for Tesla , despite divided Wall Street opinions, with the stock price showing a daily gain. Anticipation for Tesla's second-quarter delivery report is high, with expectations of around 406,000 vehicle deliveries, crucial for assessing custome
MaxLinear is strategically shifting from a cyclical chipmaker to a high-growth AI data-center infrastructure provider, capitalizing on demand in the artificial intelligence sector . The company reported strong financial performance, including 136% year-over-year growth in its AI
FuelCell Energy (NASDAQ:FCEL) Stock Soars on B. Riley Upgrade and Major Data Center Power Deal Analyst firm B. Riley upgraded FuelCell Energy (NASDAQ:FCEL) to a Buy rating , signaling strong market confidence in the clean energy provider. The company secured a significant $49 mil
Quantinuum's Market Position: The company operates in the cutting-edge quantum computing sector, utilizing a full-stack model and advanced trapped-ion technology. Analyst Price Target: A UBS (NYSE: UBS) analyst set a new price target of $78.00 for Quantinuum, indicating a potenti
BMO Capital's Upgrade: On June 29, 2026, BMO Capital upgraded its rating on Casey's General Stores to Outperform, citing a robust new three-year strategic plan. Aggressive Expansion & Sector Focus: The company plans to add over 400 new stores and accelerate growth in its high-mar
Hitek Global's current stock price of $0.28 exceeds the average analyst target price of $0.21 , suggesting potential overvaluation. Analysts project a potential downside of -26.59% for Hitek Global , indicating expert sentiment on its future stock performance. Compared to its pee
Headlines provided by Investing.com